Clinical Research Facility

Forest Hills, New York

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Forest Hills, NY
Click here to add this to my saved trials